Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity College Dublin

About this trial

This prospective, observational cohort study will evaluate the associations between wearable-derived biometrics and cardiovascular health, quantified by the American Heart Association's Life's Essential 8 framework, as well as related cardiovascular risk factors. The study aims to determine whether wearable biometrics can support the assessment of cardiovascular health and cardiovascular disease risk, both when used in isolation and in combination with point-of-care assessments.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18 years, or older

Internet access

Possession of a smartphone compatible with the Fitbit mobile app

Disqualifiers

Pregnancy

Unstable medical condition

Inability to provide informed consent

Mental or cognitive impairment precluding adherence to study protocol

Trial population

Participants will primarily include patients with moderate or poor cardiovascular health who have been diagnosed with atherosclerosis and other cardiovascular disease. A smaller proportion of individuals with good cardiovascular health, without diagnosed cardiovascular disease, will also be recruited.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 1 trial group
Group A: Patients with cardiovascular disease and healthy individuals

Trial outcomes

Primary outcomes

1

Cross-Sectional Association of Wearable Biometrics with Cardiovascular Health

The strength and direction of the associations between wearable-derived biometric data (e.g., heart rate, sleep, step count) and cardiovascular health, quantified using Life's Essential 8 score and each of its individual components. Life's Essential 8 is measured on a scale from 0 to 100, with higher scores representing better cardiovascular health. Clinical cardiovascular assessments will be paired with wearable biometric data from a window of ±2 weeks surrounding the clinical visit date.

Time frame
Baseline, Month 3, and Month 6
2

Longitudinal Association of Changes in Wearable Biometrics with Changes in Cardiovascular Health

The strength and direction of the association between changes in wearable-derived biometrics and corresponding changes in cardiovascular health, quantified using Life's Essential 8 score and each of its components, assessed over time both within and between individuals. Life's Essential 8 is measured on a scale from 0 to 100, with higher scores representing better cardiovascular health.

Time frame
Between assessments of cardiovascular health from baseline to Month 3, Month 3 to Month 6, and baseline to Month 6.

Secondary outcomes

1

Classification Performance for Life's Essential 8 Tier

Model classification performance for discriminating between Life's Essential 8 cardiovascular health tiers using wearable-derived biometrics, with and without partial imputation of Life's Essential 8 components which are measurable by point-of-care testing (diet, nicotine use, HbA1c, lipid profile, BMI, blood pressure). Life's Essential 8 tiers are defined as 'Low' (\>50), 'Moderate' (50-79), and 'High' (80-100).

Time frame
Baseline, Month 3, Month 6.
2

Prediction Accuracy of Change in Life's Essential 8 Score

Statistical model performance in estimating the direction and the magnitude of change in Life's Essential 8 score between assessment timepoints, compared with observed scores. A 10-point change in Life's Essential 8 score is clinically significant.

Time frame
From baseline to Month 3, Month 3 to Month 6, and baseline to Month 6.
3

Cross-Sectional Correlation of Wearable Biometrics with Patient-Reported Psychosocial and Behavioural Risk Factors of Cardiovascular Disease

The strength and direction of inter-individual correlation between wearable-derived biometric data and patient-reported outcome measures of alcohol intake, sleep, stress and fatigue, illness, anxiety and depression, physical activity, and quality of life.

Time frame
Baseline, Month 3, Month 6.
4

Longitudinal Correlation of Weekly and Monthly Changes in Wearable Biometrics with Patient-Reported Psychosocial and Behavioural Risk Factors of Cardiovascular Disease

The strength and direction of intra-individual correlation between wearable-derived biometric data and patient-reported outcome measures of alcohol intake, sleep, stress and fatigue, illness, anxiety and depression, physical activity, and quality of life.

Time frame
Baseline through Month 6

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University College Dublin

Lead sponsor

Beacon Hospital, Ireland

Collaborator